Celesta Capital has doubled its investments in India over the last 10 years, says Co-Founder

Its India portfolio include Arzooo, Clairvolex, Connect & Heal, Healofy, Ideaforge, Questt, Pixis, Rizzle, and more. The company recently invested $4.6 million in Indian medical diagnostics platform 5C Network's.

In an interview to CNBC-TV18, Nicholas Brathwaite, Co-founder at Celesta Capital said the company has doubled its investments in India over the last 10 years.

“Our cheque sizes have not changed significantly. We probably have increased the initial cheque size that we do in India slightly but not significantly. However our total investment that we are making in companies in India that has increased. Seven years ago, the size of the investments that we were making were probably about half of the total amount we are investing in companies today,” Brathwaite said.

Arun Kumar, Managing Partner at Celesta Capital, said all Indian companies that they have invested in can benefit from their guidance and become global.

“What excites us is the opportunity for deep technology – and that means hardware, software, semiconductors and systems where complicated technology is involved. So with the talent that exists in India, we do not see India as a cost arbitrage play, we see it as a very strong talent play. So all the companies that we invested in can benefit from our very seasoned guidance. So we see an opportunity for applying operating experience to build and scale world class companies from India," he said.